Vertex Pharmaceuticals Statistics
Total Valuation
VRTX has a market cap or net worth of $115.24 billion. The enterprise value is $105.79 billion.
Important Dates
The next estimated earnings date is Monday, February 3, 2025, after market close.
| Earnings Date | Feb 3, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
VRTX has 257.53 million shares outstanding. The number of shares has decreased by -0.91% in one year.
| Current Share Class | 257.53M |
| Shares Outstanding | 257.53M |
| Shares Change (YoY) | -0.91% |
| Shares Change (QoQ) | +1.12% |
| Owned by Insiders (%) | 0.18% |
| Owned by Institutions (%) | 93.81% |
| Float | 256.79M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 24.68 |
| PS Ratio | 10.87 |
| Forward PS | 9.95 |
| PB Ratio | 7.38 |
| P/TBV Ratio | 8.41 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 1.32 |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 9.96 |
| EV / EBITDA | 23.79 |
| EV / EBIT | 24.96 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.47, with a Debt / Equity ratio of 0.11.
| Current Ratio | 2.47 |
| Quick Ratio | 2.08 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 0.39 |
| Debt / FCF | n/a |
| Interest Coverage | 110.38 |
Financial Efficiency
Return on equity (ROE) is -2.99% and return on invested capital (ROIC) is 15.29%.
| Return on Equity (ROE) | -2.99% |
| Return on Assets (ROA) | 12.05% |
| Return on Capital (ROIC) | 15.29% |
| Revenue Per Employee | $1.97M |
| Profits Per Employee | -$88,852 |
| Employee Count | 5,400 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 5.58 |
Taxes
In the past 12 months, VRTX has paid $739.40 million in taxes.
| Income Tax | 739.40M |
| Effective Tax Rate | 284.82% |
Stock Price Statistics
The stock price has increased by +8.97% in the last 52 weeks. The beta is 0.37, so VRTX's price volatility has been lower than the market average.
| Beta (5Y) | 0.37 |
| 52-Week Price Change | +8.97% |
| 50-Day Moving Average | 473.78 |
| 200-Day Moving Average | 457.79 |
| Relative Strength Index (RSI) | 38.30 |
| Average Volume (20 Days) | 1,257,190 |
Short Selling Information
The latest short interest is 3.67 million, so 1.43% of the outstanding shares have been sold short.
| Short Interest | 3.67M |
| Short Previous Month | 4.11M |
| Short % of Shares Out | 1.43% |
| Short % of Float | 1.43% |
| Short Ratio (days to cover) | 2.64 |
Income Statement
In the last 12 months, VRTX had revenue of $10.63 billion and -$479.80 million in losses. Loss per share was -$1.86.
| Revenue | 10.63B |
| Gross Profit | 5.69B |
| Operating Income | 4.24B |
| Pretax Income | 214.70M |
| Net Income | -479.80M |
| EBITDA | 4.45B |
| EBIT | 4.24B |
| Loss Per Share | -$1.86 |
Full Income StatementBalance Sheet
The company has $6.52 billion in cash and $1.77 billion in debt, giving a net cash position of $9.45 billion or $36.71 per share.
| Cash & Cash Equivalents | 6.52B |
| Total Debt | 1.77B |
| Net Cash | 9.45B |
| Net Cash Per Share | $36.71 |
| Equity (Book Value) | 15.63B |
| Book Value Per Share | 60.65 |
| Working Capital | 5.83B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$842.60 million and capital expenditures -$263.20 million, giving a free cash flow of -$1.11 billion.
| Operating Cash Flow | -842.60M |
| Capital Expenditures | -263.20M |
| Free Cash Flow | -1.11B |
| FCF Per Share | -$4.29 |
Full Cash Flow StatementMargins
Gross margin is 53.59%, with operating and profit margins of 39.89% and -4.52%.
| Gross Margin | 53.59% |
| Operating Margin | 39.89% |
| Pretax Margin | 2.44% |
| Profit Margin | -4.52% |
| EBITDA Margin | 41.85% |
| EBIT Margin | 39.89% |
| FCF Margin | n/a |
Dividends & Yields
VRTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.91% |
| Shareholder Yield | 0.91% |
| Earnings Yield | -0.42% |
| FCF Yield | -0.96% |
Dividend DetailsAnalyst Forecast
The average price target for VRTX is $519.88, which is 16.17% higher than the current price. The consensus rating is "Buy".
| Price Target | $519.88 |
| Price Target Difference | 16.17% |
| Analyst Consensus | Buy |
| Analyst Count | 30 |
| Revenue Growth Forecast (5Y) | 9.84% |
| EPS Growth Forecast (5Y) | 13.55% |
Stock ForecastsStock Splits
The last stock split was on August 24, 2000. It was a forward split with a ratio of 2:1.
| Last Split Date | Aug 24, 2000 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
VRTX has an Altman Z-Score of 11.97 and a Piotroski F-Score of 1.
| Altman Z-Score | 11.97 |
| Piotroski F-Score | 1 |